CPT1A and metabolic dysfunction-associated steatotic liver disease: To further explore fatty acid oxidation, carnitine palmitoyltransferase 1α (CPT1α) expression was assessed, as shown in Figure 3I. In the NAFLD model group, CPT1α expression was significantly decreased compared to the control group.